Skip to content
ProPublica Donate
ProPublica Donate
Regulation

Homeowner Hell

Investigating Colorado’s Unregulated Homeowners Associations

Nearly half of Colorado lives in neighborhoods governed by homeowners associations, which have the authority to levy fines and even file for foreclosure against residents. Yet the state has done little to ensure that HOAs are not abusing this power.

7 stories published since 2022

Are Colorado’s Efforts to Curb HOA Foreclosures Working?

by Brittany Freeman, Rocky Mountain PBS, data analysis by Sophie Chou, ProPublica,

HOA Foreclosures Are a “Lose-Lose” Game for Coloradans, but These Lawyers Win Regardless of the Outcome

by Brittany Freeman, Rocky Mountain PBS, data analysis by Sophie Chou, ProPublica,

Nearly $30K Vanished From the HOA’s Account. The State Can’t Investigate the Management Company.

by Brittany Freeman, Rocky Mountain PBS,

Colorado Legislature Passes HOA Foreclosure Reform Bill

by Brittany Freeman, Rocky Mountain PBS,

Colorado HOA Foreclosure Reform Legislation Moves Forward

by Brittany Freeman, Rocky Mountain PBS,

They Faced Foreclosure Not From Their Mortgage Lender, but From Their HOA

by Brittany Freeman, Rocky Mountain PBS, with data analysis by Sophie Chou and research by Mariam Elba, ProPublica,

Roofs of houses in the foreground, Rocky Mountains in the background

Colorado Homeowners: Do You Have Experience Dealing With an HOA? Help Us Investigate.

by Brittany Freeman, Rocky Mountain PBS, and Chris Morran and Mariam Elba, ProPublica,

What We’re Watching

During Donald Trump’s second presidency, ProPublica will focus on the areas most in need of scrutiny. Here are some of the issues our reporters will be watching — and how to get in touch with them securely.

Learn more about our reporting team. We will continue to share our areas of interest as the news develops.

Photo of Sharon Lerner
Sharon Lerner

I cover health and the environment and the agencies that govern them, including the Environmental Protection Agency.

Photo of Andy Kroll
Andy Kroll

I cover justice and the rule of law, including the Justice Department, U.S. attorneys and the courts.

Photo of Melissa Sanchez
Melissa Sanchez

I report on immigration and labor, and I am based in Chicago.

Photo of Jesse Coburn
Jesse Coburn

I cover housing and transportation, including the companies working in those fields and the regulators overseeing them.

If you don’t have a specific tip or story in mind, we could still use your help. Sign up to be a member of our federal worker source network to stay in touch.

We’re trying something new. Was it helpful?

Most Read

    The Price of Remission

    When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.

    by David Armstrong,

    The DEA Once Touted Body Cameras for Their “Enhanced Transparency.” Now the Agency Is Abandoning Them.

    An internal email obtained by ProPublica said the agency made the change to be “consistent” with a Trump executive order. But at least two other federal law enforcement agencies are still requiring body cameras.

    by Mario Ariza,

    Ivanka and Donald Trump Jr. Were Close to Being Charged With Felony Fraud

    New York prosecutors were preparing a case. Then the D.A. overruled his staff after a visit from a top donor: Trump attorney Marc Kasowitz. 

    by Jesse Eisinger and Justin Elliott, ProPublica, and Andrea Bernstein and Ilya Marritz, WNYC,

    Internal VA Emails Reveal How Trump Cuts Jeopardize Veterans’ Care, Including To “Life-Saving Cancer Trials”

    Despite a congressional mandate to expand care for veterans, internal Veterans Affairs messages obtained by ProPublica paint a stark portrait of how chaotic cost cutting has already imperiled tests of treatments for cancer, opioid addiction and more.

    by Eric Umansky and Vernal Coleman,

    Why Do Americans Pay More for Prescription Drugs?

    Drug companies in the U.S. face few restraints on what to charge for their products. A bipartisan bill would penalize those companies that sell their drugs at higher prices than the average of the prices in other wealthy nations.

    by David Armstrong,

OSZAR »